Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48.
作者信息
ElSayed Nuha A, Aleppo Grazia, Aroda Vanita R, Bannuru Raveendhara R, Brown Florence M, Bruemmer Dennis, Collins Billy S, Hilliard Marisa E, Isaacs Diana, Johnson Eric L, Kahan Scott, Khunti Kamlesh, Leon Jose, Lyons Sarah K, Perry Mary Lou, Prahalad Priya, Pratley Richard E, Seley Jane Jeffrie, Stanton Robert C, Gabbay Robert A
出版信息
Diabetes Care. 2023 Sep 1;46(9):1716-1717. doi: 10.2337/dc23-ad08a.
Abstract
摘要
相似文献
1
Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48.
Diabetes Care. 2023 Sep 1;46(9):1716-1717. doi: 10.2337/dc23-ad08a.
2
Response to comment on American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetes-2015. Diabetes Care 2015;38(Suppl. 1):S41-S48.
Diabetes Care. 2015 Oct;38(10):e175. doi: 10.2337/dc15-1773.
3
Comment on American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetes-2015. Diabetes Care 2015;38(Suppl. 1):S41-S48.
Diabetes Care. 2015 Oct;38(10):e174. doi: 10.2337/dc15-0839.
4
Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S49-S67.
Diabetes Care. 2023 Sep 1;46(9):1718-1720. doi: 10.2337/dc23-ad09.
5
Erratum. Glycemic Targets. Sec. 6. In . Diabetes Care 2017;40(Suppl. 1);S48-S56.
Diabetes Care. 2017 Jul;40(7):985. doi: 10.2337/dc17-er07a. Epub 2017 May 18.
6
Addendum. 8. Obesity Management for the Treatment of Type 2 Diabetes: . Diabetes Care 2020;43(Suppl. 1):S89-S97.
Diabetes Care. 2020 Aug;43(8):1980. doi: 10.2337/dc20-ad08b. Epub 2020 Jun 5.
7
Addendum. 7. Diabetes Technology: . Diabetes Care 2020;43(Suppl. 1):S77-S88.
Diabetes Care. 2020 Aug;43(8):1981. doi: 10.2337/dc20-ad08c. Epub 2020 Jun 5.
8
Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
Diabetes Care. 2023 Sep 1;46(9):1715. doi: 10.2337/dc23-ad08.
9
Addendum. 2. Classification and Diagnosis of Diabetes: . Diabetes Care 2021;44(Suppl. 1):S15-S33.
Diabetes Care. 2021 Sep;44(9):2182. doi: 10.2337/dc21-ad09. Epub 2021 Jun 16.
10
Addendum. 11. Microvascular Complications and Foot Care: : Diabetes Care 2021;44(Suppl. 1):S151-S167.
Diabetes Care. 2021 Sep;44(9):2186-2187. doi: 10.2337/dc21-ad09b. Epub 2021 Jun 16.
引用本文的文献
1
Relative effectiveness of different exercise interventions on cardiovascular events in individuals with prediabetes: a systematic review and network meta-analysis.
BMC Sports Sci Med Rehabil. 2025 Jun 4;17(1):144. doi: 10.1186/s13102-025-01187-2.
2
The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension.
Clin Hypertens. 2024 Sep 1;30(1):24. doi: 10.1186/s40885-024-00279-4.
3
Vitamin D Status and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in a Tertiary-Level Hospital in Antananarivo, Madagascar.
Diabetes Metab Syndr Obes. 2024 May 31;17:2191-2198. doi: 10.2147/DMSO.S467316. eCollection 2024.
4
Gout risk in adults with pre-diabetes initiating metformin.
Ann Rheum Dis. 2024 Sep 30;83(10):1368-1374. doi: 10.1136/ard-2024-225652.
5
The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes.
Nutrients. 2024 May 1;16(9):1378. doi: 10.3390/nu16091378.
6
American College of Lifestyle Medicine Expert Consensus Statement: Lifestyle Medicine for Optimal Outcomes in Primary Care.
Am J Lifestyle Med. 2023 Oct 25;18(2):269-293. doi: 10.1177/15598276231202970. eCollection 2024 Mar-Apr.
7
Secondary analysis of a randomized trial testing community health educator interventions for diabetes prevention among refugees with depression: effects on nutrition, physical activity and sleep.
Int J Behav Nutr Phys Act. 2023 Sep 12;20(1):107. doi: 10.1186/s12966-023-01509-y.
8
Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience.
Front Clin Diabetes Healthc. 2023 May 9;4:1181729. doi: 10.3389/fcdhc.2023.1181729. eCollection 2023.
本文引用的文献
1
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9.
Zotero 插件